Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01632293 · ClinicalTrials.gov registry record · NA

Evaluating Intervention Responsiveness in People With Multiple Sclerosis

A NA study, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT01632293: Completed NA study, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

NCT01632293 is a NA study that has completed, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01632293, a NA study, has completed, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The purpose is to see how multiple sclerosis (MS) is associated with strength and sensation using MRI, in persons with MS. The investigators will also see whether exercise can improve these symptoms for persons with MS.

Primary Outcome

Here, we will assess whether the degree of a person's white matter integrity (i.e. for tracts of interest as measured from MRI) predicts their ability to benefit from exercise. Our prediction is that those individuals with preserved white matter integrity will show the greatest improvement in hip flexor strength.

Interventions

  • BEHAVIORAL progressive resistance training

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2012-04
Est. Completion 2015-09
Phase NA

What the finished NCT01632293 record still lists

NCT01632293 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which progressive resistance training is the first listed.

NCT01632293 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01632293 about?

NCT01632293 is a clinical study titled "Evaluating Intervention Responsiveness in People With Multiple Sclerosis". The purpose is to see how multiple sclerosis (MS) is associated with strength and sensation using MRI, in persons with MS. The investigators will also see whether exercise can improve these symptoms for persons with MS.

What is the current status of trial NCT01632293?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-04. Estimated completion is 2015-09.

What interventions are being tested in trial NCT01632293?

The interventions under investigation include: progressive resistance training (BEHAVIORAL).

Who is sponsoring clinical trial NCT01632293?

This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01632293's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01632293, the US trial registry maintained by the National Library of Medicine. NCT01632293 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.